AOR Arginine
Natural health product licensed in Canada
- Other names
- Arginine, DUONOx3,2,1
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80002697
- Status
- Active licence
- Licence date
- 24 January 2007
- Revision date
- 13 July 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Eau, Poudre de racine de carotte, Hypromellose, Sodium Stearyl Fumarate, Sorbitol, Lécithine, Cellulose - microcrystalline, Dioxyde de silicium, Palmitate d'ascorbyle, Acide citrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
L-Arginine is a conditionally essential amino acid and the main precursor in the body in the synthesis of nitric oxide (NO), now accepted to be the "endothelium-derived relaxation factor (EDRF)".
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not use if you have asthma or if you are pregnant or breastfeeding. Do not use if you have had a myocardial infarction (heart attack).
- Contre-indications
Consult a health care practitioner prior to use if you are taking cardiovascular medications, potassium-increasing drugs or sidenafil, erectile dysfunction, and/or blood thinners. Consult a health care practitioner prior to use if you suffer from cardiovascular disease and are attempting an increase in physical activity or if your cardiovascular condition worsens. Some people may experience gastrointestinal discomfort (such as diarrhea).
Source
Official Health Canada record, licence 80002697
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging